Testing effectiveness (Phase 2)Ended earlyNCT00087724
What this trial is testing
Study to Evaluate FK962 in Subjects With Mild to Moderate Alzheimer's Disease
Who this might be right for
Alzheimer's Disease
Astellas Pharma Inc 510
Showing 20 of 0 results